Modi Ventures

Modi Ventures is part of Latus new Series A round, focused on gene therapy development. Take a look!

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today a

Exciting news from Abingworth, one of our portfolio funds!

Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences; Establishes Joint Steering Committee between Launch Therapeutics and Gilead Sciences London, UK and New York, USA, February 29, 2024 - Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced a strategic development financing agreement with Gilead Sciences. The financing agreement will provide up to $210...

Modi Ventures' Founder and GP Sahir Ali recently spoke to Learning with Rishad about our thesis, raising a $32M fund in 30 days and more. Check it out!

Raising a venture fund in 30 days - Sahir Ali (Modi Ventures) Sahir Ali is a the founding general partner of Modi Ventures, an early stage venture fund investing in tech-bio startups. He is also an LP in multiple funds ...

Welcome to our revamped Modi Ventures page! We'll share a range of information here - investments, ideas, insights and fun stuff. Please connect and DM us if you have interesting opportunities or ideas! Also please visit us at www.modivc.com and https://www.linkedin.com/company/modi-venture-partners/.